{
    "Orphapacket": {
        "ORPHApacketId": "557056",
        "creationDate": "2025-06-26 11:48:15",
        "version": "1.3.42 / 4.1.8 [2025-03-03]",
        "copyright": "Orphanet (c) 2025",
        "ORPHAcode": "557056",
        "Label": "Spastic ataxia-dysarthria due to glutaminase deficiency",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_557056",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "ExternalReferences": [
            {
                "Source": "OMIM",
                "Reference": "618412",
                "DisorderMappingRelation": "E (Exact mapping: the two concepts are equivalent)"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "A rare genetic neurometabolic disease characterized by childhood onset of global developmental delay progressive spastic ataxia leading to loss of independent ambulation and elevated plasma levels of glutamine. Optic atrophy tremor and dysarthria have also been reported. Brain imaging may show cerebellar atrophy."
        },
        "Genes": [
            {
                "Gene": {
                    "Symbol": "GLS",
                    "Name": "glutaminase",
                    "ExternalReferences": [
                        {
                            "Source": "HGNC",
                            "Reference": "4331"
                        },
                        {
                            "Source": "OMIM",
                            "Reference": "138280"
                        }
                    ],
                    "DisorderGeneAssociationType": "Disease-causing germline mutation(s) (loss of function) in"
                }
            }
        ],
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "289841",
                        "Label": "Disorder of glutamine metabolism"
                    }
                ]
            },
            {
                "Parent": [
                    {
                        "ORPHAcode": "68385",
                        "Label": "Neurometabolic disease"
                    }
                ]
            },
            {
                "Parent": [
                    {
                        "ORPHAcode": "316240",
                        "Label": "Autosomal recessive spastic ataxia"
                    }
                ]
            }
        ],
        "Prevalences": [
            {
                "Prevalence": {
                    "Source": "29468182[PMID]_30987386[PMID]",
                    "PrevalenceType": "Cases/families",
                    "PrevalenceQualification": "Case(s)",
                    "PrevalenceClass": "no data",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            },
            {
                "Prevalence": {
                    "Source": "ORPHANET_29468182[PMID]_30987386[PMID]",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            }
        ],
        "AverageAgeOfOnsets": {
            "AverageAgeOfOnset": [
                {
                    "value": "Childhood"
                }
            ]
        },
        "TypeOfInheritances": {
            "TypeOfInheritance": [
                {
                    "value": "Autosomal dominant"
                }
            ]
        }
    }
}